Combination of Androgen Deprivation Therapy with Radical Local Therapy Versus Androgen Deprivation Therapy Alone for Newly Diagnosed Oligometastatic Prostate Cancer: A Phase II Randomized Controlled Trial

医学 雄激素剥夺疗法 前列腺癌 随机对照试验 危险系数 前列腺切除术 泌尿科 放射治疗 内科学 前列腺 无进展生存期 前列腺特异性抗原 置信区间 肿瘤科 外科 癌症 化疗
作者
Bo Dai,Sheng Zhang,Fangning Wan,Hongkai Wang,Junyu Zhang,Qifeng Wang,Yunyi Kong,Xuejun Ma,Miao Mo,Yao Zhu,Xiaojian Qin,Guowen Lin,Dingwei Ye
出处
期刊:European Urology Oncology [Elsevier BV]
卷期号:5 (5): 519-525 被引量:73
标识
DOI:10.1016/j.euo.2022.06.001
摘要

Previous studies suggested that men with metastatic prostate cancer might benefit from local treatment of the primary tumor.To determine whether radical local therapy (RLT) improves survival for men with oligometastatic prostate cancer (OMPCa).This open-label randomized controlled trial included patients with newly diagnosed OMPCa defined as five or fewer bone or extrapelvic lymph node metastases and no visceral metastases.Patients were randomly allocated to androgen deprivation therapy (ADT) or ADT and RLT. Men allocated RLT received either cytoreductive radical prostatectomy (RP) or prostate radiation therapy (RT) with a radical dose schedule.The primary outcome was radiographic progression-free survival (rPFS). Secondary outcomes were overall survival (OS) and prostate-specific antigen (PSA) progression-free survival.Between September 2015 and March 2019, 200 patients were randomized, with 100 men allocated to each group. The median age was 68 yr and the median PSA at diagnosis was 99 ng/ml. In the study group, 96 patients underwent RLT (85 RP and 11 RT). In the control group, 17 patients eventually received RLT (15 RP and two RT). All patients were included for an intention-to-treat analysis. After a median follow-up of -48 mo, the median rPFS was not reached in the study group and was 40 mo in the control group (hazard ratio [HR] 0.43, 95% confidence interval [CI] 0.27-0.70; p = 0.001). The 3-yr OS rate was 88% for the study group and 70% for the control group (HR 0.44, 95% CI 0.24-0.81; p = 0.008).Men with newly diagnosed OMPCa who received ADT plus RLT (mainly prostatectomy) had significantly higher rates of rPFS and OS than those who received ADT alone.This study investigated the effect of radical local therapy (RLT) of the primary tumor on survival in patents with oligometastatic prostate cancer. In our group, RLT improved radiographic progression-free and overall survival.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
徐院长发布了新的文献求助10
1秒前
华仔的应助被霖29采纳,获得10
1秒前
洁净的天德完成签到,获得积分10
2秒前
马佳闯完成签到 ,获得积分10
5秒前
future完成签到 ,获得积分10
5秒前
5秒前
152455完成签到 ,获得积分10
6秒前
蝉鸣一夏完成签到,获得积分10
6秒前
流觞曲水完成签到 ,获得积分10
8秒前
破事不糊墙完成签到,获得积分10
8秒前
犹豫大树完成签到,获得积分10
8秒前
XL完成签到,获得积分10
10秒前
guac完成签到,获得积分10
11秒前
007完成签到 ,获得积分10
12秒前
友好的晓曼完成签到,获得积分10
14秒前
清风明月完成签到,获得积分10
14秒前
sky完成签到,获得积分10
15秒前
2580852qwe完成签到 ,获得积分10
15秒前
我看看sci怎么个事完成签到 ,获得积分10
17秒前
keyIncy完成签到,获得积分10
18秒前
徐妮完成签到,获得积分10
19秒前
20秒前
暗心不语完成签到,获得积分10
20秒前
lianxin完成签到 ,获得积分10
20秒前
21秒前
23秒前
rayqiang完成签到,获得积分0
23秒前
一笑没的应助被科研通管家采纳,获得10
24秒前
rayq完成签到,获得积分10
24秒前
一笑没的应助被科研通管家采纳,获得10
24秒前
syvshc的应助被科研通管家采纳,获得50
24秒前
24秒前
大个的应助被科研通管家采纳,获得10
24秒前
zxy的应助被科研通管家采纳,获得10
24秒前
ryz99完成签到,获得积分10
25秒前
霖29发布了新的文献求助10
25秒前
Shaelyn_Cheung完成签到 ,获得积分10
26秒前
sheep发布了新的文献求助10
27秒前
小五完成签到 ,获得积分10
28秒前
28秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185571
求助须知:如何正确求助?哪些是违规求助? 9574290
关于积分的说明 21834928
捐赠科研通 7783274
什么是DOI,文献DOI怎么找? 3434577
关于科研通互助平台的介绍 2558973
邀请新用户注册赠送积分活动 2481370